Cargando…
Cardio-metabolic factors associated to mortality in patients with COVID-19
Autores principales: | Eduardo, Camey, Guillermo, Arauz, Alejandra, Cárcamo, Grecia, Celis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892332/ http://dx.doi.org/10.1016/j.metabol.2021.154987 |
Ejemplares similares
-
QTc Prolongation in SARS-CoV-2 (COVID-19) Patients Receiving Hydroxycloroquine: A Retrospective Study
por: Vlachopoylou, M., et al.
Publicado: (2021) -
Is dyslipidemia associated to mortality in patients with COVID-19?
por: Grecia, Celis, et al.
Publicado: (2021) -
High Glucose Variability Increases Mortality Risk in Patients with COVID-19
por: Guillermo, Arauz, et al.
Publicado: (2021) -
Repurposing Cardio-Metabolic Drugs to Fight Covid19
por: Battistoni, Allegra, et al.
Publicado: (2021) -
Overview of the cardio-metabolic impact of the COVID-19 pandemic
por: Barkhordarian, Maryam, et al.
Publicado: (2023)